Patent details

Basic Information

Publication number:

EP3526198

PCT Application Number:

US2017056265

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177880689

PCT Publication Number:

WO2018071622

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS

French Title of Invention:

AGONISTES D'APJ DE 3-SULFONYL-5-AMINOPYRIDINE -2,4-DIOL

German Title of Invention:

3-SULFONYL-5-AMINOPYRIDIN-2,4-DIOL-APJ-AGONISTEN

SPC Number:

Dates

Filing date:

12/10/2017

Grant date:

12/08/2020

EP Publication Date:

21/08/2019

PCT Publication Date:

19/04/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/08/2020

EP B1 Publication Date:

12/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/10/2020

Expiration date:

12/10/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/08/2020

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

BATES, J. Alex

Address:

United States (US)

2

Name:

RICHTER, Jeremy M.

Address:

United States (US)

Priority

Priority Number:

201662408272 P

Priority Date:

14/10/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4427; A61P 9/00; C07D 213/74; C07D 401/04; C07D 401/06; C07D 401/14; C07D 413/04; C07D 413/14; C07D 417/04; C07D 417/14;

Publication

European Patent Bulletin

Issue number:

202033

Publication date:

12/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages